This inventor holds 1 USPTO granted patent. Top assignee: Pharma Mar, S.a.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Chris Twelves: Innovator in Cancer Treatment
Introduction
Chris Twelves is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of cancer treatment through his innovative work. His research focuses on the development of effective medicaments for combating cancer.
Latest Patents
Chris Twelves holds 1 patent for his invention titled "Compositions and uses of ET743 for treating cancer." This patent involves the use of ET743 in the preparation of a medicament aimed at treating the human body for cancer. His work is pivotal in advancing therapeutic options for patients.
Career Highlights
Throughout his career, Chris has been associated with Pharma Mar, S.A., a company dedicated to the research and development of innovative cancer treatments. His role at Pharma Mar has allowed him to contribute to groundbreaking advancements in oncology.
Collaborations
Chris has collaborated with esteemed colleagues such as Esteban Cvitkovich and George Daniel Demetri. These partnerships have fostered a collaborative environment that enhances the development of effective cancer therapies.
Conclusion
Chris Twelves is a dedicated inventor whose work in cancer treatment exemplifies innovation in the medical field. His contributions are vital for the ongoing fight against cancer, and his patent reflects his commitment to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile